# Bicara Therapeutics Inc. (BCAX) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Bicara Therapeutics Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/BCAX/mda/fy2025/): filed 2026-03-30; accession 0001628280-26-022010 (https://www.sec.gov/Archives/edgar/data/2023658/000162828026022010/bcax-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/BCAX/mda/fy2024/): filed 2025-03-27; accession 0002023658-25-000012 (https://www.sec.gov/Archives/edgar/data/2023658/000202365825000012/bcax-20241231.htm)

Back to /company/BCAX/